ECM
TDOC icon

Endurant Capital Management’s Teladoc Health TDOC Stock Holding History

Endurant Capital Management’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-13,153
Closed -$731K – 74
2019
Q1 		$731K Buy
+13,153
New +$803K 0.29% 54

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Endurant Capital Management's TDOC Position: Q2 2019 in Review

Endurant Capital Management sold out of Teladoc Health (TDOC) in Q2 2019, closing a stake of 13,153 shares — an estimated $731K sold.

Endurant Capital Management first reported a position in TDOC in Q1 2019 and held it in 1 quarter. The position peaked at $731K in Q1 2019. 371 funds tracked by Wall St. Rank hold TDOC as of Q2 2019.

  • Endurant Capital Management reported no remaining Teladoc Health position as of Q2 2019 after selling out during the quarter.
  • Endurant Capital Management sold 13,153 Teladoc Health shares in Q2 2019, an estimated $731K.
  • Endurant Capital Management first reported a position in Teladoc Health in Q1 2019 and held it in 1 quarter.
  • Endurant Capital Management's Teladoc Health position peaked at $731K in Q1 2019.
  • 371 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2019.

Based on Endurant Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.